<p>Renal medullary carcinoma (RMC) demonstrates strong uptake of the radiotracer 18F-FDG, distinguishing it from other types of kidney cancer that often have more variable uptake. 18F-FDG PET/CT was found to be highly effective even after systemic treatment and detected additional metastases missed by </p>